MTF Biologics Debuts CartiMax Viable Cartilage Allograft

MTF Biologics and ConMed launched CartiMax® Viable Cartilage Allograft, a putty-like cartilage designed to fill lesions in the knee, foot and ankle.

CartiMax demonstrates stable viability up to one year post-cryopreservation, allowing surgeons to schedule procedures without a waiting list. Surgeons can mold and fill up to a 5cm2 lesion without...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us